Recent Updates
Recently added Catalysts
AORT Positive Sentiment Score: 65/100

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full...

Key Takeaway: Artivion, Inc. announced the release date for its fourth quarter and full year 2023 financial results, scheduled for February 15, 2024. The company will hold a teleconference at 4:30 p.m. ET on the same day to discuss these results, followed by a Q&A session with CEO Pat Mackin. This event will allow stakeholders to receive direct insights into the company’s performance and future outlook. Financial details will be available through their website and during the teleconference.

Market Sentiment Analysis

POSITIVE FACTORS

  • Artivion is set to release its financial results which could indicate growth.
  • The company continues to focus on innovative solutions in cardiac and vascular surgery.
  • The upcoming teleconference provides an opportunity for investors to gain insights directly from leadership.

Full Press Release Details

ATLANTA , Feb. 1, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT ), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2023 financial results will be released on Thursday, February 15, 2024 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin , Chairman, President and Chief Executive Officer of Artivion.
To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET . The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13742847.
The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.
About Artivion, Inc. Headquartered in suburban Atlanta, Georgia , Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com .
Contacts:
Artivion Gilmartin Group LLC
Lance A. Berry Brian Johnston / Laine Morgan
Executive Vice President & Phone: 332-895-3222
Chief Financial Officer [email protected]
Phone: 770-419-3355
SOURCE Artivion, Inc.

21 %

Frequently Asked Questions

When will Artivion release its Q4 2023 financial results?

Artivion will release its fourth quarter and full year 2023 financial results on February 15, 2024.

How can I listen to the Artivion teleconference?

Dial 201-689-8261 a few minutes before 4:30 p.m. ET on February 15 to join the teleconference.

Where can I find Artivion's financial press release?

The financial press release will be available in the Investors section on Artivion's website.

Who will host the Artivion Q&A session?

Pat Mackin, the Chairman, President, and CEO, will host the Q&A session.

What products does Artivion focus on?

Artivion specializes in aortic stent grafts, surgical sealants, heart valves, and tissues.

Last updated: Feb 1, 2024